[go: up one dir, main page]

NO832092L - Fremgangsmaate ved fremstilling av et heparinfragment - Google Patents

Fremgangsmaate ved fremstilling av et heparinfragment

Info

Publication number
NO832092L
NO832092L NO832092A NO832092A NO832092L NO 832092 L NO832092 L NO 832092L NO 832092 A NO832092 A NO 832092A NO 832092 A NO832092 A NO 832092A NO 832092 L NO832092 L NO 832092L
Authority
NO
Norway
Prior art keywords
infragment
health
preparing
procedure
medicine
Prior art date
Application number
NO832092A
Other languages
English (en)
Other versions
NO157783B (no
NO157783C (no
Inventor
Desire J Collen
Original Assignee
Kabivitrum Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kabivitrum Ab filed Critical Kabivitrum Ab
Publication of NO832092L publication Critical patent/NO832092L/no
Publication of NO157783B publication Critical patent/NO157783B/no
Publication of NO157783C publication Critical patent/NO157783C/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
NO832092A 1982-06-10 1983-06-09 Fremgangsmaate for fremstilling av et heparinfragment covalent bundet til antitrombin iii, og et mellomprodukt for fremstilling av heparinfragmentforbindelsen. NO157783C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8203611 1982-06-10

Publications (3)

Publication Number Publication Date
NO832092L true NO832092L (no) 1983-12-12
NO157783B NO157783B (no) 1988-02-08
NO157783C NO157783C (no) 1988-05-18

Family

ID=20347038

Family Applications (1)

Application Number Title Priority Date Filing Date
NO832092A NO157783C (no) 1982-06-10 1983-06-09 Fremgangsmaate for fremstilling av et heparinfragment covalent bundet til antitrombin iii, og et mellomprodukt for fremstilling av heparinfragmentforbindelsen.

Country Status (8)

Country Link
US (1) US4623718A (no)
EP (1) EP0098814B1 (no)
JP (1) JPS5925802A (no)
AT (1) ATE22899T1 (no)
CA (1) CA1205011A (no)
DE (2) DE98814T1 (no)
DK (1) DK258283A (no)
NO (1) NO157783C (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3422518A1 (de) * 1984-06-16 1985-12-19 B. Braun Melsungen Ag, 3508 Melsungen Heparin-derivate, verfahren zu ihrer herstellung, diese enthaltende arzneimittel und ihre verwendung bei der behandlung von fettstoffwechselstoerungen
US4859581A (en) * 1986-03-10 1989-08-22 Board Of Regents, The University Of Texas System Endoglycosidase assay
EP0337327A1 (en) * 1988-04-09 1989-10-18 Bioiberica, S.A. Process for the preparation of new oligosaccharide fractions by controlled chemical depolimerization of heparin
US5252557A (en) * 1988-07-25 1993-10-12 Kiyoshi Kita Administration method of antithrombin
US6562781B1 (en) * 1995-11-30 2003-05-13 Hamilton Civic Hospitals Research Development Inc. Glycosaminoglycan-antithrombin III/heparin cofactor II conjugates
US6491965B1 (en) 1995-11-30 2002-12-10 Hamilton Civic Hospitals Research Development, Inc. Medical device comprising glycosaminoglycan-antithrombin III/heparin cofactor II conjugates
US7045585B2 (en) 1995-11-30 2006-05-16 Hamilton Civic Hospital Research Development Inc. Methods of coating a device using anti-thrombin heparin
US20040229778A1 (en) * 2003-05-13 2004-11-18 Elmaleh David R. Pharmaceutical compositions of antithrombin III for the treatment of retroviral diseases
US7498130B2 (en) * 2003-05-13 2009-03-03 Massachusetts General Hospital Method of reducing viral load
CA2535446A1 (en) * 2003-08-12 2005-02-17 Hamilton Civic Hospitals Research Development Inc. Methods for preventing neurological events
CN103743837B (zh) * 2013-12-24 2015-01-21 山东泰邦生物制品有限公司 人抗凝血酶ⅲ肝素结合比例检测方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4301153A (en) 1977-03-21 1981-11-17 Riker Laboratories, Inc. Heparin preparation
JPS6040859B2 (ja) 1977-07-27 1985-09-12 喜温 三浦 抗血栓性人工医療材料
CA1136620A (en) 1979-01-08 1982-11-30 Ulf P.F. Lindahl Heparin fragments having selective anticoagulation activity
US4351938A (en) 1980-05-19 1982-09-28 Riker Laboratories, Inc. Anticoagulant substance
ATE12779T1 (de) * 1980-09-30 1985-05-15 Bayer Ag Verfahren zur herstellung eines antithrombinheparin-komplexes sowie diesen komplex enthaltende pharmazeutische mischungen.
US4446126A (en) 1980-09-30 1984-05-01 Cutter Laboratories, Inc. Antithrombin-heparin complex and method for its production
US4386025A (en) 1980-09-30 1983-05-31 Cutter Laboratories, Inc. Method of preparing antithrombin
JPS57134419A (en) 1981-02-12 1982-08-19 Eisai Co Ltd Stable anticoagulant of blood
US4526714A (en) 1982-12-13 1985-07-02 Cordis Europa N.V. Conjugates of anticoagulant and protein
US4533549A (en) 1983-01-04 1985-08-06 Lasker Sigmund E Antithrombotic agent
US4689323A (en) 1983-09-26 1987-08-25 Miles Laboratories, Inc. Covalently bound heparin--antithrombin-III complex

Also Published As

Publication number Publication date
EP0098814A1 (en) 1984-01-18
DK258283A (da) 1983-12-11
JPS5925802A (ja) 1984-02-09
EP0098814B1 (en) 1986-10-15
NO157783B (no) 1988-02-08
DE3366933D1 (en) 1986-11-20
NO157783C (no) 1988-05-18
CA1205011A (en) 1986-05-27
ATE22899T1 (de) 1986-11-15
DK258283D0 (da) 1983-06-07
US4623718A (en) 1986-11-18
DE98814T1 (de) 1984-06-20

Similar Documents

Publication Publication Date Title
DE3787403D1 (de) Verwendung von spezifischen Monosacchariden zur Herstellung eines Arzneimittels zur Verhinderung von Metastasen maligner Tumore.
ES8501414A1 (es) Procedimiento de sintesis organica de oligosacaridos
DE3650215D1 (de) Orientiertes, silanvernetztes Polyäthylen-Produkt von ultrahohem Molekulargewicht und Verfahren zu dessen Herstellung.
DE3166441D1 (en) Novel antihistamines, process for their preparation and pharmaceutical compositions containing them
ATE16591T1 (de) Neue quartaere 6,11-dihydro-dibenzo-(b,e)-thiepin11-n-alkyl-norscopinether und verfahren zu deren herstellung.
IL61708A0 (en) Platinum(iv)diamine-complexes,a process for the preparation thereof,process for the preparation of a medicine using such a platinum(iv)-diamine-complex for the treatment of ccancer as well as the shaped medicine thus obtained
DE3787459D1 (de) Aminogruppenhaltige Polymerisate, ihre Herstellung und ihre Verwendung.
BR8304973A (pt) Mistura de polimero compativel
FR2379553A1 (fr) Nouveaux photoinducteurs de polymerisation, compositions photopolymerisables les contenant et procede de photopolymerisation
HU896510D0 (en) Novel anion-exchange polymers, process for preparing them and pharmaceutical compositions containing them
NO832092L (no) Fremgangsmaate ved fremstilling av et heparinfragment
JPS5795916A (en) Stabilization of vii factor activity in whole blood or blood plasma
DE3484315D1 (de) Messvorrichtung zur herstellung von nach mass hergestellten artikeln.
FR2495154B1 (fr) 5'-aminoalkyl-4', 4, 8-trialkylpsoralenes, leur procede de production et composition pharmaceutique les contenant
DE59008005D1 (de) Verfahren zur Herstellung von hochmolekularen Copolyarylensulfiden.
PT88275A (pt) Processo para a preparacao de composicoes farmaceuticas contendo 5-amino ou amino substituido-1,2,3-triazois uteis como agentes antiproliferativos
JPS57167924A (en) Chemokinesin and chemotaxin of leucocyte and inflammatory tissue
BG40318A3 (bg) Метод за получаване на имуноглобулинови производни на виндезина
SE8704158D0 (sv) Mikrosferer, forfarande for framstellning derav och anvendning derav
ATE7139T1 (de) N-aryl-n'-imidazol-2-yl-harnstoffe, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.
IL58103A0 (en) Sila-substituted 1,4-dihydropyridine derivatives their production and pharmaceutical compositions containing them
FI882278A0 (fi) Parannettuja kromikatalyyttikoostumuksia ja polymerointimenetelmä, jossa niitä käytetään
ATE30426T1 (de) Peneme, sie enthaltende pharmazeutische zusammensetzungen und verfahren zu ihrer herstellung.
FI891375L (fi) Icke-vaevd, tygliknande produkt med anvaendande av ett bakteriecellulosabindemedel och foerfarande foer framstaellning av den.
ATE86251T1 (de) Polycyclische verbindungen, ihre herstellung und sie enthaltende rezepturen.